NCT00886691 2022-02-04Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerGOG FoundationPhase 2 Completed150 enrolled 11 charts